Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
167 hedge funds and large institutions have $696M invested in Meridian Bioscience Inc in 2015 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 62 increasing their positions, 46 reducing their positions, and 11 closing their positions.
82% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 11
64% more call options, than puts
Call options by funds: $1.7M | Put options by funds: $1.04M
35% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 46
5% more funds holding
Funds holding: 159 → 167 (+8)
4% less capital invested
Capital invested by funds: $723M → $696M (-$27.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PP
Prudential plc
London, England,
United Kingdom
|
+$8.51M |
| 2 |
Renaissance Technologies
New York
|
+$7.04M |
| 3 |
MCM
McKinley Capital Management
Anchorage,
Alaska
|
+$3.81M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.78M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$3.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$40.9M |
| 2 |
Neuberger Berman Group
New York
|
-$4.93M |
| 3 |
FAM
Fred Alger Management
New York
|
-$2.17M |
| 4 |
Two Sigma Investments
New York
|
-$2.15M |
| 5 |
Millennium Management
New York
|
-$2M |
VIVO Hedge Fund Activity: Q2 2015 in Review
167 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q2 2015, worth a combined $696M — down 3.8% from $723M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new VIVO positions and 11 closed out — a net gain of 9 holders — while 62 added to existing stakes and 46 trimmed.
The largest buyer was Prudential plc, adding an estimated $8.51M. The largest seller was Fidelity Investments, exiting entirely with an estimated $40.9M sold.
- 167 institutional investors held Meridian Bioscience Inc (VIVO) as of Q2 2015, up from 159 in Q1 2015.
- Funds reported $696M of Meridian Bioscience Inc stock for Q2 2015, down 3.8% quarter-over-quarter.
- 20 funds opened new Meridian Bioscience Inc positions in Q2 2015 and 11 closed out, a net change of +9 holders.
- The largest Meridian Bioscience Inc buyer in Q2 2015 was Prudential plc, an estimated $8.51M added.
- The largest Meridian Bioscience Inc seller in Q2 2015 was Fidelity Investments, an estimated $40.9M sold.
Based on aggregated 13F filings for Q2 2015.